A biotechnology company focused on the discovery, development and commercialization of cancer therapy products.


Updates from The Motley Fool

Latest updates on Poniard Pharmaceuticals, Inc. from Fool.com.
10 Stocks to Shake the Market

Some stocks are one-hit wonders, making a big splash when they first appear, then quickly fizzlin...



Stock Performance

View Interactive PARD Charts
Sponsored by

Key Data Points

Primary metrics and data points about Poniard Pharmaceuticals, Inc..
Current Price: $0.12
Prev Close: $0.12
Open: $0.00
Bid: $0.00
Ask: $0.00
Day's Range: $0.00 - $0.00
52wk Range: $0.06 - $0.22
Volume: 0
Avg Vol 1,296
Market Cap: $180MM
P/E (ttm): -0.01
EPS (ttm): $0.00
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Poniard Pharmaceuticals, Inc..
CAPS Rating 0 out of 5
 
47 Outperform
9 Underperform
CAPS All Stars
 
10 Outperform
2 Underperform

How do you think Poniard Pharmaceuticals, Inc. will perform against the market?



You pick for Poniard Pharmaceuticals, Inc. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Poniard Pharmaceuticals, Inc..

A biotechnology company focused on the discovery, development and commercialization of cancer therapy products.

  • Exchange: NASDAQOTH
  • Sector: Healthcare
  • Industry: Biotech